Samsung Life Insurance stock
032830.KSKSCSamsung Life Insurance Co., Ltd., Financial ServicesISIN KR7032830002
50Score 50 out of 100, Neutral
Price and trend
47 / 100
Price history
+50% in one yearThe chart shows daily closes over 17 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 11% below it.
Since November 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 53).
The price is 50% below its 52-week high. Largest decline in 17 years: 77% (November 2017 to March 2020).
Chart figures for advanced users
- SMA 50$204.83
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$211.71
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)53
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$108.54
- The lowest closing price of the last twelve months.
- Resistance$372.53
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Samsung Life Insurance Co., Ltd. belongs to the Insurance (Life) industry (South Korea) and, with a market value of $33.65B, is number 12 of 34 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $17.98B (up 0.4% year on year) and earnings of $1.73B (up 9.3%).
- MEQIRI Score 50 out of 100 (Neutral): rank 852 of 975 in Financial Services, median 68.
Show more
- The P/E is 19.5 (Insurance (Life) median 13.4, own median of recent years 9.3).
- Our model puts fair value at $99.16, with the price 89% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 24.6% a year through 2028 (estimates from 14 analysts).
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 66
- Earnings per share growingUp 12.7% a year since 2020.
Weaknesses
- Volatile share priceVolatility 71% a year over the last 12 months.Stability 66
- Richly valuedP/E 19.5, Insurance (Life) median 13.4, own median 9.3.Valuation 46
- Revenue shrinkingRevenue down 3.1% a year since 2020.Growth 40
The score is held back by growth and profitability.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 49 to 50.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $66.11 and expensive above $198.32 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $69.71 (cash-flow model) and $128.60 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.3%. At 9.3% the fair value would be $93.35, at 7.3% it would be $107.87.
Valuation metrics
Half from the dividend model, half from earnings times the industry P/E (13.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue rose 0.4% on the prior year. Revenue has stayed largely stable since 2006.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 12%, net 10%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 23 Feb 2027in 102 days
- Last reported
- 13 Aug 2026EPS reported $2.88 (expected $2.92)in line with expectations
Analyst estimates
Analysts have raised their 2027 earnings estimate by 6.4% since 24 Oct 2026.
- Earnings per share
- $13.80+5.3%
- Revenue
- $714.34M−1.4%
- Earnings per share
- $23.24+6.4%
- Revenue
- $781.8M0.0%
MEQIRI has stored the estimates since 24 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Samsung Life Insurance
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
975 rated companies in Financial Services
- This company
- 50
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Insurance (Life)
The next larger and next smaller companies by market value
- Life Insurance Corporation of IndiaLICI.NS $54.32B75
- Cathay Financial Holding2882.TW $50.01B71
- Prudential FinancialPRU $41.99B65
- Dai-ichi Life Holdings8750.T $41.98B74
- PrudentialPUK $30.99B61
- New China Life Insurance601336.SS $23.91B70
- SBI Life InsuranceSBILIFE.NS $19.41B60
- KGI Financial Holding2883.TW $18.27B71
ETFs that hold Samsung Life Insurance
Held by 48 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers MSCI Korea UCITS ETF 1CDBX8 | 1.10% | 0.45% | €445.58M |
| Franklin FTSE Korea UCITS ETFFLXK | 0.96% | 0.09% | €3.93B |
| iShares Ageing Population UCITS ETF2B77 | 0.33% | 0.40% | €813.42M |
Show 5 more
| Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF (USD) DistributingVGEJ | 0.31% | 0.15% | €2.61B |
| iShares MSCI EM CTB Enhanced ESG UCITS ETFEDM2 | 0.22% | 0.18% | €7.25B |
| Amundi MSCI EM Asia ESG Broad Transition UCITS ETF AccLCUA | 0.19% | 0.25% | €661.06M |
| HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USDH411 | 0.18% | 0.45% | €400.6M |
| WisdomTree Emerging Markets ex-State Owned Enterprises UCITS ETF AccumUSDXSOE | 0.18% | 0.32% | €17.98M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₩1,334.10)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 13 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.